NCT01959542View on ClinicalTrials.gov

Early Changes In Multiparametric MRI In Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Prostate Cancer
Interventions
DEVICE

MRI

OTHER

PSA Blood Test

Serum PSA will also be subsequently checked on the same day as each follow-up MR is performed, i.e. TP 1, 2 and 3, and right after finishing EBRT. 1-2 mls of blood will be sampled per blood test.

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT01959542 - Early Changes In Multiparametric MRI In Prostate Cancer | Biotech Hunter | Biotech Hunter